Thus, the loss of intracellular GSH in the presence of active generation of hydroperoxy-phospholipids could occur through several active mechanisms, including formation of GSH, export of GSSG, inadequate replenishment of GSH, or insufficient levels of GSSG reductase, each directly or indirectly dependent on the generation of hydroperoxy-phospholipids
Foundayo (orforglipron), a newer GLP-1 option, offers flexibility with no dietary restrictions
Clinicians managing these presentations often run longer initial courses and then taper to a maintenance frequency, such as three to four times per week, before eventual discontinuation pending symptom assessment
The injectable drug, made by the pharmaceutical company Eli Lilly, has the active ingredient tirzepatide, which had been approved in May 2022 to treat type 2 diabetes under the name Mounjaro
Yes, for most people, Hashimoto's is not a reason to avoid GLP-1 medications